Tracy A. Glauser, MD
Associate Director, Cincinnati Children's Research Foundation
Director, Comprehensive Epilepsy Center
Co-Director, Genetic Pharmacology Service
Cincinnati Children's Hospital Medical Center
Professor, UC Department of Pediatrics
Mary E. Thompson, PhD, RN, CPNP-PC
Assistant Professor, Nursing
MGH Institute of Health Professions
CME: 1.0 AMA PRA Category 1 CreditTM
NAPNAP CE: 1.0 contact hour (0.5 of which contains pharmacology content)
In the United States, an estimated 460,000 children have active epilepsy, and approximately 750,000 children have a history of epilepsy. Epilepsy is a complex disorder that requires careful monitoring and management. Newer pharmacologic options for the treatment of focal and generalized seizures may provide more effective treatment options in the pediatric population. In addition to managing epilepsy itself, it is important to recognize and manage comorbidities, particularly neurobehavioral or psychiatric comorbidities, as well as provide meaningful education to patients and caregivers. This activity will address the treatment of epilepsy in the pediatric population, including the recognition and management of comorbidities, and provide guidance for educating patients and their caregivers.
This activity is jointly provided by the National Association of Pediatric Nurse Practitioners, Penn State College of Medicine, and MCM Education.
This activity is designed for pediatricians, pediatric nurse practitioners, and other pediatric clinicians involved in the diagnosis and treatment of pediatric patients with seizures and/or epilepsy.
Upon completion of this educational activity, the participant should be able to:
- Improve the recognition of pediatric seizures/epilepsy and an understanding of when to refer patients for specialty care.
- Apply evidence-based guidelines in the initial management of pediatric seizures and/or epilepsy.
- Recognize and address treatment failures in pediatric epilepsy and appropriately manage comorbidities and side effects of pharmacologic therapy.
- Promote adherence to treatment regimens by implementing strategies to enhance patient and caregiver knowledge about pediatric epilepsy.
Tracy A. Glauser, MD, has disclosed the following:
Consultant, Supernus Pharmaceuticals, Inc.
Royalties, Assurex Health
Mary E. Thompson, PhD, RN, CPNP-PC, has nothing to disclose.
Penn State faculty and staff involved in the development and review of this activity have nothing to disclose.
Barbara J. Martin, MD, medical writer, has nothing to disclose.
Kathleen Hines, MCM Education VP, Editorial Affairs, has nothing to disclose.
Terry Ann Glauser, MD, MPH, MCM Education VP, Medical Affairs, has nothing to disclose.
It is the policy of the National Association of Pediatric Nurse Practitioners and Penn State College of Medicine to ensure balance, independence, objectivity and scientific rigor in all of their educational activities including those which are sponsored and cosponsored. All faculty are expected to disclose any significant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation. The intent of this disclosure is not to prevent a presenter with significant financial interest or other relationship from making the presentation, but rather to provide the audience with information with which they can make their own judgments. It remains for the audience to determine whether the speaker's interests or relationships may influence the presentation with regard to exposition or conclusion. Faculty are also expected to openly disclose any off-label, experimental, or investigational use of drugs or devices in their presentations.
Please consult full prescribing information before using any product mentioned in this activity. If using products in an investigational, off-label manner, it is the responsibility of the prescribing clinician to monitor the medical literature to determine recommended dosages and uses of the drugs. Neither the publisher nor the providers promote the use of any agent outside of approved labeling.
This program is accredited for 1.0 NAPNAP CE contact hours (0.5 of which contains pharmacology content) per the National Association of Pediatric Nurse Practitioners Continuing Education Guidelines.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Penn State College of Medicine and MCM Education. Penn State College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Penn State College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Credit is awarded to participants who score 80% or better on the post-test.
The online activity will take approximately 60 minutes to complete.
For questions regarding CME credit, contact Penn State Continuing Education at (717) 531-6483 or ContinuingEd@hmc.psu.edu. Please reference activity code G5981-17-T.
Commercial Support Statements
Supported by independent educational grants from Lundbeck LLC and Upsher-Smith Laboratories, Inc.
Minimum System Requirements: • Pentium III, 600 MHz or Equivalent Processor • 512 MB of RAM • Windows XP, Vista, or 7 • Mac OS X • 800x600 Monitor Resolution • 16-bit Color • 16 bit Sound Card with Speakers
- Please turn off all pop-up blockers to allow access to the educational activity.
- Click on the "Start program" icon at the bottom of this page. If you are not already registered as a user of this website, this will bring you to the login/registration page where you will be able to register as a new CMEcorner.com member or check existing registration information. When ready, click on the "Continue to Program" icon at the bottom of the screen.
- The next screen will permit you to check for or download the Flash player required to run this program and to begin the program presentation. The activity will take approximately 60 minutes to complete.
- After you have finished reviewing the activity, click on the "Post-test" button.
- Instructions for completing and submitting the post-test and evaluation are provided on the post-test screen.
©2016, MCM Education. All rights reserved. None of the contents may be reproduced in any form without prior written permission from the publisher. The opinions expressed in this educational activity are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, the National Association of Pediatric Nurse Practitioners, Penn State College of Medicine, Lundbeck LLC, or Upsher-Smith Laboratories, Inc. Any medications, diagnostic procedures, or treatments discussed by the faculty should not be used by clinicians or other health care professionals without first evaluating their patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.